Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    novocure
Show Display Options
Rank Status Study
1 Recruiting Safety, Feasibility and Effect of TTFields Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma
Condition: Ovarian Carcinoma
Interventions: Device: NovoTTF-100L(O);   Drug: Paclitaxel
2 Recruiting Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Condition: Glioblastoma Multiforme
Interventions: Device: NovoTTF-100A device;   Drug: Temozolomide
3 Recruiting Safety Feasibility and Effect of NovoTTF-100L Together With Gemcitabine for Front-line Therapy of Advanced Pancreatic Adenocarcinoma
Condition: Pancreatic Adenocarcinoma
Interventions: Device: NovoTTF-100L;   Drug: Gemcitabine
4 Recruiting Effect of NovoTTF-100A in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment
Condition: 1-5 Brain Metastases From Non-Small Cell Lung Cancer
Interventions: Device: NovoTTF-100A device;   Other: Best Standard of Care
5 Recruiting NOVOTTF-100A+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
Conditions: RECURRENT GLIOBLASTOMA;   Brain Tumor
Intervention: Device: NOVOTTF-100A
6 Recruiting Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
Condition: Recurrent Glioblastoma Multiforme
Intervention: Device: NovoTTF-100A
7 Recruiting Pilot Study of NovoTTF-100A for Recurrent Atypical and Anaplastic Meningioma
Condition: Brain Cancer
Intervention: Device: NovoTTF-100A
8 Recruiting NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: Glioblastoma;   Brain Neoplasms
Interventions: Procedure: electric field therapy;   Procedure: quality-of-life assessment;   Genetic: laboratory biomarker analysis
9 Completed NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   NSCLC
Intervention: Device: NovoTTF-100L
10 Completed Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
Condition: Recurrent Glioblastoma Multiforme
Intervention: Device: NovoTTF-100A
11 Recruiting NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Biological: Bevacizumab;   Device: NovoTTF-l00A;   Other: Quality of Life Assessment

Indicates status has not been verified in more than two years